A fully automated deep learning pipeline for micro-CT-imaging-based densitometry of lung fibrosis murine models.

Journal: Respiratory research
Published Date:

Abstract

Idiopathic pulmonary fibrosis, the archetype of pulmonary fibrosis (PF), is a chronic lung disease of a poor prognosis, characterized by progressively worsening of lung function. Although histology is still the gold standard for PF assessment in preclinical practice, histological data typically involve less than 1% of total lung volume and are not amenable to longitudinal studies. A miniaturized version of computed tomography (µCT) has been introduced to radiologically examine lung in preclinical murine models of PF. The linear relationship between X-ray attenuation and tissue density allows lung densitometry on total lung volume. However, the huge density changes caused by PF usually require manual segmentation by trained operators, limiting µCT deployment in preclinical routine. Deep learning approaches have achieved state-of-the-art performance in medical image segmentation. In this work, we propose a fully automated deep learning approach to segment right and left lung on µCT imaging and subsequently derive lung densitometry. Our pipeline first employs a convolutional network (CNN) for pre-processing at low-resolution and then a 2.5D CNN for higher-resolution segmentation, combining computational advantage of 2D and ability to address 3D spatial coherence without compromising accuracy. Finally, lungs are divided into compartments based on air content assessed by density. We validated this pipeline on 72 mice with different grades of PF, achieving a Dice score of 0.967 on test set. Our tests demonstrate that this automated tool allows for rapid and comprehensive analysis of µCT scans of PF murine models, thus laying the ground for its wider exploitation in preclinical settings.

Authors

  • Elena Vincenzi
    Department of Computer Science, Bioengineering, Robotics and Systems Engineering, University of Genoa, Genoa, Italy.
  • Alice Fantazzini
    Department of Experimental Medicine, University of Genoa, Via Leon Battista Alberti, 2, 16132, Genoa, Italy. alice.fantazzini@edu.unige.it.
  • Curzio Basso
    Camelot Biomedical Systems S.r.l, Via Al Ponte Reale, 2, 16124, Genoa, Italy.
  • Annalisa Barla
    DIBRIS, Università degli Studi di Genova, Genova, Italy. annalisa.barla@unige.it.
  • Francesca Odone
    Department of Computer Science, Bioengineering, Robotics and Systems Engineering, University of Genoa, Genoa, Italy.
  • Ludovica Leo
    Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Laura Mecozzi
    Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Martina Mambrini
    Department of Veterinary Science, University of Parma, Parma, Italy.
  • Erica Ferrini
    Department of Veterinary Science, University of Parma, Parma, Italy.
  • Nicola Sverzellati
    Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Franco Fabio Stellari
    Chiesi Farmaceutici S.P.A, Corporate Pre-Clinical Research and Development, Largo Belloli, 11/A, 43122, Parma, Italy. fb.stellari@chiesi.com.